Your browser doesn't support javascript.
loading
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.
Zheng, Yulong; Mislang, Anna Rachelle Austria; Coward, Jermaine; Cosman, Rasha; Cooper, Adam; Underhill, Craig; Zhu, Jianqing; Xiong, Jianping; Jiang, Ou; Wang, Hong; Xie, Yanru; Zhou, Yuefen; Jin, Xiaoping; Li, Baiyong; Wang, Zhongmin Maxwell; Kwek, Kon Yew; Xia, Dennis; Xia, Yu; Xu, Nong.
Afiliación
  • Zheng Y; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Mislang ARA; Adelaide Cancer Centre, Kurralta Park, Australia. Anna.Mislang@icon.team.
  • Coward J; Icon Cancer Centre, South Brisbane, QLD, Australia.
  • Cosman R; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia.
  • Cooper A; Western Sydney University School of Medicine, Liverpool, Australia.
  • Underhill C; Border Medical Oncology, Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, Australia.
  • Zhu J; Department of Gynecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), No.1 Banshandong Road, Gongshu District, Hangzhou, Zhejiang, China.
  • Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zheng street, Nanchang, Jiangxi, China.
  • Jiang O; Department of Tumor Surgery, The Second People's Hospital of Neijiang, No.470 xinjaing Road, Dongxing District, Neijiang, Sichuan, China.
  • Wang H; Department of Oncology, The Third Hospital of Nanchang, No.2 XiangShan South Road, Nanchang, Jiangxi, China.
  • Xie Y; Department of Oncology, Lishui City Central Hospital, No.289 Kuocang Road, Lishui, Zhejiang, China.
  • Zhou Y; Department of Oncology, Lishui City Central Hospital, No.289 Kuocang Road, Lishui, Zhejiang, China.
  • Jin X; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Li B; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Wang ZM; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Kwek KY; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Xia D; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Xia Y; Akeso Biopharma,Inc., Shennong Road, Zhongshan, 528400, China.
  • Xu N; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. nongxu@zju.edu.cn.
Cancer Immunol Immunother ; 71(10): 2371-2379, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35165764
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gastrointestinales / Inhibidores de Puntos de Control Inmunológico / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gastrointestinales / Inhibidores de Puntos de Control Inmunológico / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China